The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the National Institutes of Health (NIH), awarded a firm-fixed-price purchase order contract worth $10,122.00 to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostic products. The contract is for the delivery of RNAscope HiPlex Probes Assay Kits, which are specialized reagents used for the precise visualization and quantification of RNA biomarkers in cells and tissues. This contract supports NIAAA's research efforts, likely in areas related to alcohol abuse and addiction. ACD, a subsidiary of Bio-Techne Corporation, is a prominent federal contractor serving various NIH agencies through purchase order contracts. The contract has a completion date of March 31, 2025 and does not have a set-aside designation.
Generated 3/11/25, 9:50 AM